Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Bimekizumab effectively treats scalp cellulitis and improves quality of life.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

CTP-543 is generally safe for treating alopecia areata.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Cal/BD aerosol foam effectively treats scalp psoriasis, improving symptoms and patient satisfaction.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.